Judge Orders Hospital to Treat COVID Patient With Experimental Drug

Thomas A. Russo, MD, professor of medicine and chief of the Division of Infectious Diseases, was quoted for a story on WKBW on a judge’s ruling that a local COVID-19 patient be allowed to receive an experimental drug as part of her treatment. “Some studies report a benefit — some studies do not,” said Russo. “Ivermectin is believed to have both anti-inflammatory properties and potentially anti-viral against the new coronavirus.” The story also ran in The Desert Review.